EUVIMEDEUVIMED entdecken
Vergleichsstudie

Genomic Concordance Between Primary and Oligo‐Recurrent Lesions in Pancreatobiliary Cancer

Keita Sonoda iD, Hideyuki Hayashi iD, Minoru Kitago, Yuta Abe, Yasushi Hasegawa iD, Shutaro Hori, Masayuki Tanaka iD, Yutaka Nakano, Hiroshi Nishihara, Yuko Kitagawa

Journal of Hepato-Biliary-Pancreatic Sciences · 2026-04 · 33 (4) · 322-329

DOI: 10.1002/jhbp.70065 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, online erschienen am 19.01.2026. Verfasst von Keita Sonoda und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Neoplasm Recurrence, Local, Bile Duct Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Purpose The introduction of oligo‐recurrence (OR) as a subtype of metastasis offered new hope, suggesting that local therapies may lead to prolonged survival/cure in selected cases. This study compared the genomic alterations between primary tumors and matched OR lesions in patients with pancreatic ductal adenocarcinoma (PDAC) and cholangiocarcinoma (CCA).

Methods

Eight patients with OR of PDAC or CCA were eligible. Genomic DNA was extracted from the tissue samples of primary tumors and matched OR lesions. Comprehensive genomic profiling (CGP) was performed using a panel of 216 cancer‐related genes. The genomic profiles of the two groups were compared.

Results

Among 17 tumor samples from eight patients, 32 genomic mutations were identified in nine genes. A total of 48 copy number alterations were found across 31 distinct genes. Driver genomic mutations were concordant between the primary tumors and OR lesions in all cases, whereas differences in passenger mutations were observed in two cases. Five of the eight patients remained recurrence‐free, including two pancreatic cancer cases who remained recurrence‐free for > 4 years after surgery.

Conclusions

The genomic mutation statuses of primary tumors and OR lesions were concordant, and patients' prognosis was significantly better than that of patients with other Stage IV cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsNeoplasm Recurrence, LocalBile Duct NeoplasmsCarcinoma, Pancreatic DuctalCholangiocarcinomaHumansFemaleMaleAgedMutationMiddle AgedPrognosisGenomics

Stichwörter der Autor:innen

cholangiocarcinomacomprehensive genome profilingoligo‐recurrencepancreatic ductal adenocarcinoma

Autor:innen und Institutionen

  • Department of Surgery, Keio University School of Medicine, Tokyo, Japan.
  • Center for Cancer Genomics, Keio University School of Medicine, Tokyo, Japan.
  • David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

ORCID-Profile: Keita Sonoda, Hideyuki Hayashi, Yasushi Hasegawa, Masayuki Tanaka

Zitieren

APA

Sonoda, K., Hayashi, H., Kitago, M., Abe, Y., Hasegawa, Y., Hori, S., Tanaka, M., Nakano, Y., Nishihara, H., & Kitagawa, Y. (2026). Genomic Concordance Between Primary and Oligo‐Recurrent Lesions in Pancreatobiliary Cancer. Journal of Hepato-Biliary-Pancreatic Sciences, 33(4), 322-329. https://doi.org/10.1002/jhbp.70065

Vancouver

Sonoda K, Hayashi H, Kitago M, Abe Y, Hasegawa Y, Hori S, et al. Genomic Concordance Between Primary and Oligo‐Recurrent Lesions in Pancreatobiliary Cancer. Journal of Hepato-Biliary-Pancreatic Sciences. 2026;33(4):322-329. doi:10.1002/jhbp.70065

BibTeX
@article{Sonoda2026,
  author = {Sonoda, Keita and Hayashi, Hideyuki and Kitago, Minoru and Abe, Yuta and Hasegawa, Yasushi and Hori, Shutaro and Tanaka, Masayuki and Nakano, Yutaka and Nishihara, Hiroshi and Kitagawa, Yuko},
  title = {Genomic Concordance Between Primary and Oligo‐Recurrent Lesions in Pancreatobiliary Cancer},
  journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
  year = {2026},
  volume = {33},
  number = {4},
  pages = {322--329},
  doi = {10.1002/jhbp.70065}
}
Kostenlos starten →